Hitting a Plateau: Why Weight Loss Stalls and What Actually Helps

Every weight loss curve flattens. It flattens in the trials, it flattens with surgery, and it flattens on medication. What varies is what people do when it happens — and whether that response is based on physiology or on frustration.

In the trials of GLP-1 medications, weight typically declines steeply for a period and then the curve bends and levels off, with people largely holding their loss thereafter. That flattening is a normal feature of the data, not an anomaly at the end of it. Our complete guide to GLP-1 medications covers the class overall; this article is about the part of treatment where the number stops moving and people start making decisions.

Why weight loss slows

A smaller body costs less to run

The largest part of this is not mysterious. Energy expenditure is closely related to body mass. Moving a smaller body requires less energy, and maintaining less tissue requires less energy. Somebody who has lost a meaningful amount of weight now burns less doing exactly what they were doing before.

Which means the deficit that was producing steady loss shrinks on its own. Nothing has gone wrong, nothing has been abandoned. The gap between intake and expenditure has narrowed because expenditure fell, and eventually the two meet. That meeting point is the plateau.

Metabolic adaptation

On top of the mass effect, there is a further reduction in energy expenditure that is larger than body composition alone predicts. This is often called adaptive thermogenesis. The body becomes somewhat more efficient: resting expenditure falls a little more than expected, and spontaneous movement — fidgeting, gesturing, standing rather than sitting, the general restlessness that accounts for a surprising amount of daily energy use — tends to decrease without anyone deciding to move less.

Hormonal signalling shifts too. Leptin falls as fat mass falls. Ghrelin tends to rise. The system that defends body weight is doing what it evolved to do, and it does not know the difference between deliberate weight loss and a food shortage. This is the same physiology that drives regain after treatment stops, covered in what happens when you stop a GLP-1.

Intake drifts, quietly

This one needs saying without a hint of accusation attached. As the body adjusts to a medication, appetite suppression often becomes less pronounced than in the first weeks. Portions creep. Snacks return. Almost nobody notices, because it is gradual and because the eating still feels restrained relative to before treatment. Under-reporting of intake is a well-documented finding, and it is not deliberate.

The point is not that you should feel caught out. It is that the drift is invisible without measurement.

Loss of lean mass

If a substantial share of the weight lost has been lean tissue, resting metabolic rate falls further than it needed to. That makes the plateau arrive earlier and sit lower. It is one of the more actionable contributors, which is why protein intake and resistance training keep appearing in this article.

What a plateau actually means

Two things, and the difference matters.

The first is that you have reached the weight at which your current intake and your current expenditure balance. That is a description of an equilibrium, not a verdict on you or on the treatment.

The second is that maintaining a reduced weight is itself an outcome. This gets lost. In the trials, holding a meaningful weight loss for a sustained period is a result, because the untreated trajectory for most people is upward. The metabolic benefits that came with the loss — blood pressure, glycaemic control, lipids, sleep apnoea, joint load — do not evaporate because the number stopped falling. If your plateau is well below where you started and you stay there, treatment is doing something, whatever it feels like.

The change many people value most is not the weight at all. If the constant preoccupation with food has stayed quiet — what patients call food noise — that is a real, continuing effect during a stall.

What to do — and what not to

The productive responses are less satisfying than either of those, because they are slow.

Measure honestly for two weeks

Not forever, and not as a punishment. Two weeks of recording everything, including drinks, cooking oil and the things eaten standing up, tells you whether intake has drifted. If it has, you have a specific thing to adjust. If it has not, you have ruled out the most common explanation and can look elsewhere. Either result is worth having. If food logging has been a trigger for disordered eating in the past, skip this and say so — there are other ways in.

Prioritise protein

Protein is the most satiating macronutrient and the one that supports retention of lean mass. When total intake falls, it is the one most likely to be squeezed. Putting it first in the meal, while appetite and stomach capacity still exist, is the practical version of this.

Train against resistance, and progress it

The single most useful addition for most people at a plateau. It defends lean mass, which supports resting metabolic rate, and it changes body composition in ways the scale cannot see — which is precisely why the scale is a poor instrument for judging this period. Two or three sessions a week working the major muscle groups, with the load increasing over time, is the standard recommendation.

Look at sleep and alcohol

Short sleep is associated with increased appetite and worse body composition outcomes during weight loss. Alcohol contributes energy and disrupts sleep. Neither is a moral matter; both are variables with measurable effects.

Ask for a medication and health review

Several common medications promote weight gain — some antidepressants, some antipsychotics, corticosteroids, certain beta blockers, some anticonvulsants, insulin and sulfonylureas. Sometimes an alternative exists; sometimes it does not, and knowing which is useful. Untreated hypothyroidism, worsening sleep apnoea and, rarely, other endocrine conditions can also be relevant. A stall that arrives suddenly after a long steady period, or comes with new symptoms, deserves clinical assessment rather than a change in diet.

Consider whether the dose is right — with your prescriber

If you are not at the maximum labelled dose and have been stable for some time, escalation may be appropriate. That is a clinical decision made with a prescriber, on a defined schedule, with side effects monitored. If you are already at the maximum, there is nothing further to go to, and pushing beyond it produces adverse effects rather than results. Switching to a different agent is sometimes reasonable — the two drugs differ in ways covered in semaglutide vs tirzepatide, and a switch is a legitimate clinical move rather than an admission of anything. What no clinician can tell you is whether any change will restart weight loss, and one who promises that is guessing.

Give it time

Plateaus of a month or two are common and frequently resolve without any intervention at all. Reacting hard to four flat weeks usually causes more problems than it solves.

When a plateau means something else

Occasionally a stall is a signal rather than an equilibrium. Weight regain while taking the medication as prescribed, a sudden change after long stability, new symptoms alongside the stall, or a plateau at a weight where you remain unwell all warrant a proper clinical look. So does the situation where you are barely eating and the weight still is not moving, which is not a sign of insufficient effort and needs investigating rather than intensifying.

The frame that helps

Weight loss is not a linear process executed with varying degrees of competence. It is a negotiation with a regulatory system that responds to everything you do, and that system is good at its job. A plateau is that system arriving at a new equilibrium.

Treating it as a failure produces panic responses. Treating it as expected produces better decisions. If you have stalled and want an actual review, our weight management service includes follow-up appointments for exactly this, and you can book a consultation. These are prescription medications requiring clinical evaluation, and a clinician may conclude that a change of dose, a change of drug, or no change at all is the right answer.